Robert J. Michel net worth and biography

Robert Michel Biography and Net Worth

CFO of Daxor

Bob is a certified public accountant and gained his public accounting experience at Price Waterhouse in New York the predecessor firm to pwc. Bob graduated from Villanova University’s School of Business with a degree in Business Administration and has an MBA from St. John’s University. He has a diverse background with more than 30 years of financial experience in manufacturing, advertising and financial services. Prior to joining Daxor Corporation, Bob was CFO of Asta Funding for 7 years, a publicly traded diversified financial services company that traded on the Nasdaq. He enjoys running, cycling and has hiked across the Grand Canyon.

What is Robert J. Michel's net worth?: The estimated net worth of Robert J. Michel is at least $190.62 thousand as of March 10th, 2025. Mr. Michel owns 17,050 shares of Daxor stock worth more than $190,619 as of September 22nd. This net worth evaluation does not reflect any other investments that Mr. Michel may own. Learn More about Robert J. Michel's net worth.
How do I contact Robert J. Michel?: The corporate mailing address for Mr. Michel and other Daxor executives is 350 Fifth Avenue, Suite 7120, New York, NY, 10118. Daxor can also be reached via phone at 212-244-0555 and via email at [email protected]. Learn More on Robert J. Michel's contact information.
Has Robert J. Michel been buying or selling shares of Daxor?: Robert J. Michel has not been actively trading shares of Daxor over the course of the past ninety days. Most recently, on Monday, March 10th, Robert J. Michel bought 1,000 shares of Daxor stock. The stock was acquired at an average cost of $8.00 per share, with a total value of $8,000.00. Following the completion of the transaction, the chief financial officer now directly owns 17,050 shares of the company's stock, valued at $136,400. Learn More on Robert J. Michel's trading history.
Who are Daxor's active insiders?: Daxor's insider roster includes Michael Feldschuh (President & Chief Executive Officer), and Robert Michel (CFO). Learn More on Daxor's active insiders.
Are insiders buying or selling shares of Daxor?: In the last twelve months, Daxor insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $9,070.00. The most recent insider tranaction occured on April, 8th when CEO Michael Richard Feldschuh bought 1,000 shares worth more than $9,070.00. Insiders at Daxor own 51.5% of the company. Learn More about insider trades at Daxor.
Information on this page was last updated on 4/8/2026.

Robert J. Michel Insider Trading History at Daxor

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/10/2025	Buy	1,000	$8.00	$8,000.00	17,050
3/27/2024	Buy	750	$8.70	$6,525.00	11,300
12/1/2023	Buy	180	$7.75	$1,395.00	10,430
11/24/2023	Buy	500	$7.94	$3,970.00	10,250
10/13/2023	Buy	500	$9.02	$4,510.00	7,750
3/22/2019	Buy	750	$13.02	$9,765.00	3,250
11/7/2018	Buy	2,500	$7.42	$18,550.00	2,500

Robert J. Michel Buying and Selling Activity at Daxor

Daxor Company Overview

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

Today's Range

Now: $11.35

$11.00

$11.61

50 Day Range

MA: $10.54

$9.67

$11.72

2 Week Range

Now: $11.35

$8.56

$14.76

Volume

18,101 shs

Average Volume

40,892 shs

Market Capitalization

$66.25 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.26